|
Sign In to gain access to subscriptions and/or personal tools.
|
Manufacturing Desire:
The Commodification of Female Sexual Dysfunction
Jennifer R. Fishman
Department of Bioethics, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106-4976, USA; fax: +1 216 368 8713jennifer.fishman{at}case.edu
The process of bringing new drugs to market interweaves commercialism, science, clinical medicine, and governmental regulation. Through their authority and public persona as medical experts, academic clinical trial researchers studying these pharmaceuticals are integral to this process, serving as mediators between producers (the pharmaceutical companies) and consumers (clinicians and patients) of new drugs through a complex set of exchange networks. Using examples from my ethnographic research on the search for pharmaceuticals to treat what has become known as female sexual dysfunction, this paper explores the links academic researchers make with drug manufacturers and consumer markets. Academic researchers have become an integral aspect of drug development, not only by conducting clinical trial research, but also by participating in a number of other activities that assist pharmaceutical companies in identifying and creating new markets. In this paper, I examine how researchers attend professional meetings where they present clinical trial data, lecture at continuing medical education conferences, and offer themselves as ‘experts’ to raise awareness about disorders and their treatments. Modifying a sociology of technology approach, this paper focuses on the actors in the social network who mediate the junctions between technological producers and consumers. This extends work in this area through theorizing the linkages between exchange networks, commodification techniques, and technoscientific developments.
Key Words: biomedicine • clinical trials • commercialism • medical education • pharmaceutical drugs • Viagra
Social Studies of Science, Vol. 34, No. 2,
187-218 (2004)
DOI: 10.1177/0306312704043028
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. Abraham and C. Davis
Drug Evaluation and the Permissive Principle: Continuities and Contradictions between Standards and Practices in Antidepressant Regulation
Social Studies of Science,
August 1, 2009;
39(4):
569 - 598.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Sismondo
Ghosts in the Machine: Publication Planning in the Medical Sciences
Social Studies of Science,
April 1, 2009;
39(2):
171 - 198.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. Tiefer
The New View in Activism and Academics 10 Years On
Feminism Psychology,
November 1, 2008;
18(4):
451 - 456.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Epstein
The rise of 'recruitmentology': clinical research, racial knowledge, and the politics of inclusion and difference.
Social Studies of Science,
October 1, 2008;
38(5):
801 - 832.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H. Hartley and C.-L. Coleman
News media coverage of direct-to-consumer pharmaceutical advertising: implications for countervailing powers theory
Health (London) ,
January 1, 2008;
12(1):
107 - 132.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. Tiefer
The Viagra Phenomenon
Sexualities,
July 1, 2006;
9(3):
273 - 294.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. L. Marshall
The New Virility: Viagra, Male Aging and Sexual Function
Sexualities,
July 1, 2006;
9(3):
345 - 362.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H. Hartley
The 'Pinking' of Viagra Culture: Drug Industry Efforts to Create and Repackage Sex Drugs for Women
Sexualities,
July 1, 2006;
9(3):
363 - 378.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Sismondo
Pharmaceutical Maneuvers
Social Studies of Science,
April 1, 2004;
34(2):
149 - 159.
[PDF]
|
|
|
|
|
